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Abstract.  The extracellular matrix molecule cytotactin 
is a multidomain protein that plays a role in cell migra- 
tion, proliferation, and differentiation during develop- 
ment. To analyze the structure-function relationships 
of the different domains of this glycoprotein, we have 
prepared a  series of fusion constructs in bacterial ex- 
pression vectors.  Results obtained using a  number of 
adhesion assays suggest that at least four independent 
cell binding regions are distributed among the various 
cytotactin domains. Two of these are adhesive; two 
others appear to be counteradhesive in that they in- 
hibit cell attachment to otherwise favorable substrates. 
The adhesive regions were mapped to the fibronectin 
type III repeats II-VI and the fibrinogen domain. The 
morphology of the cells plated onto these adhesive frag- 
ments differed; the cells spread on the fibronectin type 
III repeats as they do on fibronectin, but remained 
round on the fibrinogen domain. The counteradhesive 
properties of the molecule were mapped to the EGF- 
like repeats and the last two fibronectin type III re- 
peats,  VII-VIII.  The latter region also contained a  cell 
attachment activity that was observed only after prote- 
olysis of the cells. Several cell types were used in 
these analyses, including fibroblasts, neurons, and 
glia, all of which are known to bind to cytotactin. 
The different domains exert their effects in a  concen- 
tration-dependent manner and can be inhibited by an 
excess of the soluble molecule, consistent with the hy- 
pothesis that the observed properties are mediated by 
specific receptors.  Moreover, it appears that some of 
these receptors are restricted to particular cell types. 
For example, glial cells bound better than neurons to 
the fibrinogen domain and fibroblasts bound better than 
glia and neurons to the EGF fragment. These results 
provide a basis for understanding the multiple activi- 
ties of cytotactin and a  framework for isolating differ- 
ent receptors that mediate the various cellular responses 
to this molecule. 
C 
YTOTACTIN is an extracellular matrix glycoprotein 
that has important functions during morphogenesis, 
histogenesis, and tumor formation. The molecule ex- 
hibits a site-restricted distribution during development (15, 
59), which may be controlled by other developmentally im- 
portant genes. The cytotactin promoter region reveals a rich 
array of regulatory motifs with homology to the DNA bind- 
ing sequences for homeotic proteins and growth factors (39) 
and has recently been shown to be an in vitro target of  homeo- 
domain-containing proteins (40).  The restricted spatiotem- 
poral expression of cytotactin that results from its develop- 
mental regulation is tightly linked to a number of cellular 
primary processes, including adhesion (29), migration (13, 
32, 69), proliferation (12, 14), differentiation (50), epithelial- 
mesenchymal interactions (3, 4), and cell death (74). 
Cytotactin,  which  is  also  known  as  tenascin  (11), J1 
220/200 (43), hexabrachion (21, 31), the glioma-mesenchy- 
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mal extracellular matrix protein (6), and myotendinous anti- 
gen (8),  is composed of polypeptides of 190, 200, and 220 
kD when isolated from chicken brain (29).  Variation in the 
polypeptide structure arises from alternative splicing of  tran- 
scripts from a single gene (37, 38, 66). The polypeptides are 
disulfide-linked to form a multimeric structure (29, 34). EM 
of the rotary-shadowed molecule has revealed a character- 
istic six-armed structure, called a hexabrachion (21, 22), in 
which six polypeptides are linked through disulfide bonds at 
their aminotermini.  The  sequence of cytotactin reveals  a 
multidomain structure (38,  66)  with homologies to three 
other protein families. The amino-terminal portion contains 
the cysteine involved in interchain disulfide bonding, fol- 
lowed by an array of 13 repeats of 31 amino acids in length 
that resemble those found in EGE These EGF-like repeats 
are followed by a variable number of repeats similar to fibro- 
nectin type III repeats. In the chicken, cytotactin polypep- 
tides contain between 8 and 11 type HI repeats as a conse= 
quence of alternative RNA splicing. Different variants have 
been shown to be expressed preferentially at certain times 
and anatomical sites during development (59) and they may 
have different binding or morphogenetic functions (42, 54, 
57).  The carboxy-terminal portion of cytotactin is homol- 
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and contains a putative Ca  2+ binding site. 
Early studies of cell attachment to cytotactin-coated sur- 
faces suggested that multiple modes of binding to the mole- 
cule existed.  For example, fibroblasts bind both to intact 
cytotactin and to a chymotryptic fragment derived from the 
carboxy-terminal end of the protein (24).  These binding ac- 
tivities are inhibitable by peptides containing the amino acid 
sequence RGD and by antibodies to specific regions of the 
cytotactin  protein. In contrast to their rounded cell morphol- 
ogy on intact cytotactin, cells exhibit a spread morphology 
on the chymotryptic fragment. Using a  variety of recom- 
binant fragments of tenascin, a smaller region of the mole- 
cule has been identified as a cell binding site, but no spread- 
ing was observed (66).  In these studies, a fragment in the 
amino-terminal  region  containing the  EGF  domains  ap- 
peared to prevent cell binding to other substrates. Together, 
these observations suggested that at least two binding activi- 
ties are  present in intact cytotactin, one in the carboxy- 
terminal half of the protein, mediating cell attachment and 
flattening, and one in the amino-terminal portion, responsi- 
ble for so-called anti-adhesive effects (66) and rounding of 
cells exposed to the molecule (12, 24). Studies on the effects 
of cytotactin on neural attachment and neurite outgrowth 
have suggested at least one additional interactive site on the 
molecule based on antibody inhibition studies (16, 23, 26, 35, 
47, 72). 
The remarkable pattern of distribution throughout devel- 
opment and the complex multidomain structure of cytotactin 
suggest that it may play multiple roles during morphogene- 
sis. That each type of protein domain in cytotactin appears 
in several different proteins suggests that individual domains 
may represent independent functional units. These observa- 
tions have prompted us to search for functions of the various 
domains.  To  do  this,  recombinant  protein  fragments  of 
cytotactin were made containing specific regions spanning 
almost the entire molecule. Cell attachment and morphology 
of cells plated on substrates coated with each of the frag- 
ments were then analyzed. Three different classes of cells 
were examined, fibroblasts, glia, and neurons, all of which 
have been shown to bind to intact cytotactin in various assays 
(12, 24, 33, 48). In contrast to previous mapping studies that 
identified a single cell binding site and a repulsive site (24, 
66), at least four nonoverlapping sites on the molecule were 
found to interact with the cell surface. Cell attachment was 
sensitive to the method of preparation of the single cell sus- 
pension; for example, one cell binding site was seen in cells 
prepared by trypsin treatment but not in cells prepared with 
EDTA. The results suggest that multiple sites on cytotactin 
mediate its adhesive and counteradhesive effects  on cells; 
these effects are likely to be mediated by multiple, specific 
cell surface receptors. 
Materials and Methods 
Fusion Protein cDNA Constructs 
Seven different constructs containing cytotactin eDNA inserts were made 
by subcloning eDNA fragments into either the pGEX-2T or -3X vectors in 
the correct translational reading frame (Pharmacia, Uppsala, Sweden). The 
fusion proteins all consist of the carboxy-terminal portions of glutathione- 
S-transferase  (GST) l fused to the cytotactin regions.  As described below, 
the GST portion was removed by proteolytic cleavage. The different fusion 
proteins are designated as follows. EGF contains all the EGF repeats; FN1 
contains the proximal fibronectin type HI repeats  (ii-VI); FN2 contains 
fibronectin  type HI repeats II-VI and includes the three alternatively  spliced 
fibroncctin  type Ill repeats (VaVbVe);  FN3 contains the last two fibronoctin 
type HI repeats with the exception of the 13 amino-terminal amino acids 
of repeat VIII (VII and VIR); Fg contains the entire fibrinogen domain and 
includes  the  13  amino-terminal amino acids  of fibronectin repeat VIII; 
FNFgl contains the last two fibronectin type HI repeats (VII and VIII) and 
the first 71 amino acids of the fibrinogen  domain; FNFg2 contains the entire 
fibrinogen domain and the last two fibronectin type HI repeats (see Fig.  1). 
The numbering of base pairs refers to that given by Jones et al. (38). The 
EGF fusion protein was made by subcloning a 1.35-kb EcoRI eDNA frag- 
ment (Frederick Jones, unpublished observations) isolated from )~gtl  1 bac- 
teriophage into the EcoRI site of pGEX-2T. This eDNA fragment spans all 
the EGF-like  repeats of cytotactin from bp 830 to bp 2,182. 
The FN1 cytotactin-GST fusion protein was generated by excising the 
1,780-bp eDNA insert from pECS02  with BamI-II (37).  The ends of this 
cDNA were filled using Klenow to generate blunt ends. The insert derived 
from pEC802 was further digested with EcoRI and ligated into EcoRI/SmaI 
digested  pGEX-3X  vector.  The resulting 1,280-bp  insert spans from bp 
2,414 (Baml-II site) to bp 3,694 (EcoRI). 
The FN2 fusion protein construct was made using )~gtll containing a 4.5- 
kb cytotactin eDNA insert (38).  EcoRI digestion generated two fragments 
of 3.8 and 0.7 kb. The 3.8-kb fragment was subcloned into the EcoRI site 
of Bluescript KS vector (Stratagene,  La Jolla, CA). Plasmid DNA was pre- 
pared (51) and digested with BamHI to cut a site in the internal portion of 
the insert and of the plasmid. The ends of the BamHI fragment were filled 
using DNA polymerase (Klenow fragment) to generate blunt ends, and sub- 
sequently digested with EcoRI.  The resulting 2,099-bp eDNA was ligated 
into EeoRI/SmaI in pGEX-3X vector.  The 2,099-bp eDNA spans from the 
BamHI site at bp 2,414 to the EeoRI site at bp 4,513 and includes the 819-bp 
of the alternatively  spliced  region. 
The FN3 fusion protein was also made from pEC803 (40).  A 500-bp 
BgllI/EcoRI fragment was isolated from pEC803 and the 5'protruding ends 
were filled with T4 polymerase. This fragment was subcloned into the Smal 
site of pGEX-2T, and the correct orientation was determined by restriction 
analysis of the clones.  This construct spans from bp 4,513 (ECORI site) to 
bp 5,013 (Bglii site). 
The FNFgl fusion protein was made by excising a 779-bp EcoRI frag- 
ment from pEC803 (38) and subcloning it into the EcoRI site of pGEX-2T. 
This clone spans the cytotactin eDNA sequence from bp 4,513 (EeoRI site) 
to bp 5,292  (EcoRl site). 
The FNFg2  fusion protein was made from pECS03.  A  1,549-bp clone 
was made by ligating the 780-bp EcoRI insert from pEC803  and a 769-bp 
EcoRI insert obtained from the 3' most cytotactin eDNA clone (38) into 
Blueseript KS (pCG2).  The insert in pCG2 extends from bp 4,515 (EcoRl) 
site to bp 6,061. 
The Fg was made by excising a 1,020-bp BgllI/Xmnl insert from pCG2, 
and the 5' protruding ends were filled with T4 polymerase and then ligated 
into the Smal site of pGEX-2T. This clone spans from bp 5,013 (BgllI site) 
to bp 6,033 (XmnI site). 
Preparation, Purification, and Cleavage of 
Fusion Proteins 
The protocol used for induction and purification of the fusion proteins has 
been reported (52, 53) and is described briefly here. E.  coli strain NM522 
(Stratagene) was transformed with GEX plasmids under selection with am- 
pieillin. An ampieillin-resistant  colony was used to inoculate 100 ml of LA- 
broth (L-broth/ampicillin 50/~g/ml) (51) and was incubated at 37~  with 
agitation for 10 h. These cultures were used to inoculate 900 ml of LA-broth 
(10-fold dilution) which were then further incubated for 3-4 h at 250C with 
agitation, until an optical density of 1.0 at 650 run was reached. Isopropyl 
~/-thiogalactopyranoside  (IPTG)  (Sigma  Chemical Co.,  St.  Louis,  MO), 
was then added to a final concentration of 0.1 mM and the cultures were 
incubated for an additional 20 h at 25~  with agitation. The bacterial cells 
were harvested at 9,000 rpm in a GSA rotor for 10 min, and the pellet was 
resuspended in 50 ml of L-buffer consisting of 50 mM Tris-HC1, pH 7.5, 
25% sucrose,  0.5%  NP-40 and 5 mM MgC12. 
The resuspended cells were partially lysed by three cycles of freeze thaw- 
1. Abbreviation  used in this paper:  GST, glutathione-S-transferase. 
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at 4"C. The sonication was repeated five times for 1 rain. The lysate was 
centrifuged at 10,000 rpm for 20 min in an SS 34 rotor, and the supernatant 
was rotated at --6 rpm for 1 h with 14 ml of  glutathione-Sepharose  4B beads 
(Pharmacia) at 4~  The beads were washed three times with 5 vols of GST- 
wash buffer consisting of 20 mM Tris-HCI, pH 7.5, 2 mM MgClz and 1 
mM DTT (Sigma Chemical Co.). 
The fusion protein was eluted serially three times with two bead volumes 
of GST-elution buffer consisting of 50 mM Tris-HCl, pH 9.6, and 5 mM 
glutathione (Sigma Chemical Co.). Proteolytic cleavage of the fusion pro- 
teins was performed while the proteins were still attached to the glutathione 
beads. The beads were equilibrated in cleavage buffer consisting of 50 mM 
Tris-HCl, pH 7.5,  150 mM NaCI, and 1 or 2.5 mM CaCI2 when thrombin 
or activated factor Xa were used, respectively. The cleavage was done in 
one bead volume, using 10 t~g of  thrombin for the EGF and Fg fusion protein 
or 10/~g of activated factor Xa for FN1.  Factor Xa was activated at 370C 
for 5 min, using 1 ng of activating enzyme per 1 #g of factor Xa in a buffer 
containing 8 mM Tris HCI, pH 8.0, 70 mM NaCI, and 8 mM CaCI2 (65). 
After cleavage, the beads were pelleted and the proteins eluted as described 
above. The supernatants and glutathione eluates were dialyzed overnight 
against H20 at 4~  and lyophilized. Each fraction was analyzed for purity 
by SDS-PAGE (44) in  10 or 12%  gels, and by Western blotting (71). 
Protein Analysis 
The amount of protein obtained varied according to the size of the fusion 
protein; in general, the smaller the protein the larger the amount of protein 
recovered. For example, fusion proteins of '~70 kD yielded 20-40 nag and 
those of around  50  kD  yielded 80-100  mg.  The protein samples were 
digested overnight in 1 N NaOH/0.02 % Triton X-100 and protein concentra- 
tions were determined by the Lowry procedure (49). BSA was used as the 
standard protein and this method was sensitive to as little as 1/~g of  protein. 
Immunoblotting 
To determine that the fusion proteins obtained corresponded to those con- 
taining cytotactin sequences, immunoblotting was performed after resolu- 
tion  of the cytotactin  fusion proteins on  SDS-PAGE and  transfer onto 
nitrocellulose (71).  The rabbit anti-cytotactin polyclonal antibodies were 
previously characterized (34). 
Cell Preparations 
The following cells were obtained from the American Type Culture Collec- 
tion (Rockville, MD):  neuroblastomas SK-N-SH, IMR-32 and neuro2A; 
NCTC 929 clone of strain L (L-929); NIH-3T3; myeloma P3X63AgSU.1; 
glioma C6. The U251MG glioma cell line was a gift from Dr. Wolfgang Ret- 
tig (Memorial Sloan Kettering Cancer Center, New York) and the G2624 
glioma (68) was a gift from Dr. Steven E. Pfeiffer (University of Connecti- 
cut Health Center, Farmington, CT). Mouse sarcoma 180 cells transfected 
with L-CAM (S180-L)  (55).  Primary chicken embryo fibroblasts (CEFs) 
were prepared as described in (24) and primary chicken glia were obtained 
from E9 chicken brains as described (27, 28). 
All cells were grown at 37~  in a humidified atmosphere of 10% CO2 
in air.  For binding assays, cells were harvested in a divalent cation-free 
buffered medium consisting of HBSS, lacking MgCI2,  MgSO4,  and CaCI2 
(Gibco Laboratories, Grand Island, NY), and including 20 mM Hepes, pH 
7.5, and 5 mM EDTA. The ceils were incubated with 5 ml of the buffer for 
5-20 rain depending on the cell type, The cells were recovered, spun in a 
clinical centrifuge for 3 rain at 10,000 rpm and resuspended in 1 ml of bind- 
ing buffer consisting of I  x  S-MEM (Gibco Laboratories), 20 mM Hepes, 
pH 7.5,  1 mM CaCI2,  and layered over a 9 ml 3.5% BSA gradient, spun 
in a clinical centrifuge for 3 min at 10,000 rpm, washed twice with binding 
buffer, resuspended, and counted using a Neubauer chamber. The cells were 
resuspended in binding buffer to a  density of 6  ￿  105 cells/ml for the 
gravity assay or I  x  105 cells/ml for the centrifugation assay and were kept 
on ice until use. 
Different dissociation treatments were used to test the binding of L-929 
cells to the cleaved and uncleaved FN3 fragment of cytotactin. These cells 
were harvested using 0.25% trypsin (2x  recrystallized, Cooper Biomedi- 
cal, Malvern, PA), 5 mM EDTA, a mixture of  5 mM EDTA and 0.25 % tryp- 
sin, or 5 mM EDTA treatment followed by washing in divalent cation-free 
buffer and then 0.25% trypsin. All of these preparations were done in diva- 
lent cation-free medium. In all of these treatments, the cells were incubated 
for 5 min at 37~  washed in 1 x  DMEM (Gibco Laboratories) containing 
10%  calf serum,  then washed two more times in binding medium and 
counted using a hemocytometer. 
Centrifugal Cell Attachment Assay 
In the centrifugation assay, the cells were briefly spun in a U-shaped well 
that had been precoated with the protein to be tested and blocked with ex- 
cess albumin. The equilibrium between the centrifugal force that pulls that 
cell to the bottom of the well and the force of the cell-substrate adhesion 
determines the pattern observed in the well. On a nonadhesive substrate, 
the centrifugal force predominates and the cells are driven to the bottom 
of the plate into a tight pellet. As the strength of the cell-substrate adhesion 
increases, the cells become more likely to bind to the substrate as they con- 
tact it resulting in a ring pattern around the sides of the well. The diameter 
of the cell-free area inside this ring is used as a measure of the adhesivity 
of the substrate. 
96-well polystyrene (Falcon 3910; Becton Dickinson and Co., Sunnyvale, 
CA) or polyvinyl chloride rnicrotiter plates (Falcon 3911) with U-shaped 
wells were incubated with 40 t~l/well of protein in PBS and the wells were 
washed and blocked with blocking buffer containing 20 mg/ml of BSA in 
PBS, pH 7.5. A volume of 100/xl of a cell suspension containing 1-5  x 
104 cells was placed in each well and the plate was centrifuged at 250 g for 
1 rain. The pattern of cells in each well was observed using dark field mi- 
croscopy and the ring diameter was measured. 
Gravity Cell Attachment Assay 
In the gravity assay, a single cell suspension is allowed to settle for a fixed 
period of time onto a substrate that has been coated with the different pro- 
teins to be tested (24). After washing the unbound and loosely bound cells, 
the attachment and morphology of those cells remaining on the dish were 
analyzed. 
To prepare protein-coated substrates, eight separate drops (1.5/d each 
in PBS) containing different concentrations of protein were placed in a cir- 
cular array near the center of a polystyrene dish (Falcon 1008) in a humid 
atmosphere to prevent drying. After 30 min, the dish was washed three 
times with PBS, and incubated with blocking buffer for a minimum of 30 
rain. After blocking, the dish was rinsed once with PBS, and 250 #1 of a 
cell suspension was added. The cells were incubated at 37~  typically for 
55 min, except where noted, and washed three times in PBS with gentle 
swirling. The bound cells were fixed with 1% glutaraidehyde, observed by 
phase-contrast microscopy, and counted using a 10 or 20  x  objective and 
an eyepiece reticle. Cells were counted in four predetermined fields that 
when combined represented 10% of the dot area. To quantitate cell spread- 
ing, attached cells were examined using an inverted microscope and the 
number of phase-dark, polygonal, flattened cells was determined visually. 
lodination of  Fusion Proteins 
The fusion proteins were iodinated using enzymatic iodination with a mix- 
ture of lactoperoxidase and glucose oxidase immobilized onto hydrophilic 
microspheres  (Enzymobeads;  Bio-Rad  Laboratories,  Richmond,  CA). 
~200 t~g of  fibronectin and Img of fusion proteins were iodinated at a time. 
To a solution of I0 mg/ml of fusion protein (500 #1) in 0.2 M phosphate 
buffer, pH 7.5, 350/~1 of Enzymobead reagent was added, followed by 125 
#1 of 2 % glucose and 2-3 mCi of Na 12Sl (New England Nuclear, Boston, 
MA) (100 mCi/ml). The iodination was allowed to proceed at room temper- 
ature for 40 min, and the reaction was terminated by passing the mixture 
through a gel fltration column PH-19 Sephadex G-25M (Pharmacia). The 
iodinated protein was eluted with 6 ml of PBS. The first 2 ml of PBS were 
discarded and the next 4 rnl were collected in 1-rnl aiiquots. The samples 
were dialyzed against PBS at 4~  for 8 h, with three changes of four liters 
each. The iodinated proteins were stored at 4~  and the protein concentra- 
tion was determined by the modified Lowry method as described above to 
determine the specific activity.  The purity of each preparation was assessed 
by SDS-PAGE using 10-12 % gels (44) under reducing conditions, followed 
by autoradiography. 
Determination of  Protein Binding to Plastic 
The iodinated proteins were diluted using PBS or PBS solutions containing 
10, 30, or 100/~g/rnl of fibronectin. A volume of 1.5/~1 was spotted on poly- 
styrene dishes (four drops per plate), and incubated in a  humidified at- 
mosphere for 30 rain at room temperature. During the incubation, the di- 
ameter of the drop was measured through a 2.5  x  lens using a micrometer. 
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dishes were rinsed once with PBS, and each dish yeas  cut in four sections, 
each of which contained an individual radioactively  labeled area, and sec- 
tions were then counted. From the diameter of each drop and the specific 
activity of each protein, the amount  of protein bound per square millimeter 
was determined. A similar protocol was followed  to determine binding to 
96-well dishes using 40 #1 of protein solutions per well for 30 min. The 
wells were then blocked for 1 h, washed, cut, and counted. 
cleaved fusion proteins were used to prepare solutions of the 
appropriate molarity: FN1, 72.9 kD; FN2,  103.0 kD; EGF, 
72.6 kD; FN3, 44.4 kD; FNFgl, 55.1 kD; Fg, 63.3 kD; and 
FNFg2,  82.6  kD.  The  contribution  of the  glutathione-S- 
transferase portion of the fusion proteins in each fragment 
is 26 kD, which served as control (CON) in all of the studies 
described below. 
Results 
Expression and Characterization  of Cytotactin 
Fusion Proteins 
Seven different fusion proteins,  synthesized and named as 
described in Materials and Methods,  together represented 
almost the entire cytotactin molecule (Fig. 1) with the excep- 
tion of the disulfide-rich amino-terminal portion and a small 
portion of the fibronectin type III repeats I and II. The purity 
of the fragments was assessed by SDS-PAGE (Fig. 2 A) and 
by Western blotting of the fragments (Fig. 2 B).  The FN3 
and Fg fusion proteins appeared as single molecular species. 
EGE  FN2,  and  FN1  exhibited  multiple  species  each  of 
which showed antibody reactivity by Western blotting, sug- 
gesting that the multiple components arose from proteolysis 
during the purifcation procedure. The fusion proteins were 
cleaved proteolytically as described in Materials and Meth- 
ods with either thrombin or activated factor Xa. They were 
further purified to remove the bacterial GST-cleaved portion 
as shown in Fig. 2 A for EGE FNI, and FN3 before testing 
them for cell binding activity (see below). After cleavage, the 
FN2 fragment could not be purified in sufficient yield from 
the GST protein for further analysis.  The fibrinogen frag- 
ment was in GEX-2T and the GST portion was cleaved and 
recovered.  Since fibrinogen is a  physiological substrate of 
thrombin, an intact protein was not recovered and therefore 
this fragment was tested only in its uncleaved state. 
The calculated molecular masses of the fusion proteins 
differ from the apparent molecular masses shown in Fig. 2. 
The  following  calculated  molecular  weights  for  the  un- 
Cell Attachment and Morphology on Surfaces Coated 
with Cytotactin Fragments 
Cell  attachment  and  morphology  in  the  presence  of the 
different cytotactin fragments were determined in the gravity 
assay (24)  (Figs.  3  and 4).  Representative cell lines from 
three different cell types were used:  fibroblasts (NIH-3T3, 
Fig.  3,  3T3 and Fig.  4),  neurons  (neuro2A,  Fig.  3, N2A), 
and glia (Fig. 3, U251MG). The binding of each protein to 
the plastic culture  dishes  was quantitated  as described  in 
Materials and Methods and was proportional to the coating 
concentration in each case in which a single molecule was 
coated on the surface. 
All cell types attached well on fibronectin-coated surfaces 
(Fig. 3, FN); NIH-3T3s and U251MGs spread after attach- 
ment, and neuro2A cells extended processes. Fewer ceils of 
each cell type bound to cytotactin than to fibronectin, how- 
ever (Fig. 3, CT). The neuro2A ceils did not attach at all and, 
consistent  with  previous  results,  NIH-3T3  and  U251MG 
cells attached but remained round (24,  34).  When cell at- 
tachment to surfaces coated with each of the cytotactin frag- 
ments at the same molar concentration was compared, strik- 
ing differences were observed both among the cell types and 
among the different fragments. Few cells bound to the EGF 
fragment (none for neuro2As) (Fig.  3, EGF), and the cells 
that did bind remained round.  The NIH-3T3 and U251MG 
cells attached and spread on fragments FN1 (Fig. 3, FN1) and 
FN2 (Fig.  3, FN2);  at high fragment concentrations,  cells 
completely covered the area coated with the fragment. The 
binding of neuro2A cells to these fragments was much lower 
than that observed on fibronectin, although the bound cells 
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Figure I. Model of cytotactin 
and  pGEX  fusion  proteins. 
The primary structure of cyto- 
tactin  is shown at the top of 
the  figure (38).  (~-~) amino- 
terminal region; (~) EGF-like 
repeats;  (n)  FN  type III re- 
peats; (I) alternatively spliced 
repeats; and (~) fibrinogen re- 
gion. The dots above the struc- 
ture  represent  potential  gly- 
cosylation  sites,  small  lines 
below denote cysteine residues. 
The arrows are potential gly- 
cosaminoglycan addition sites 
and the RGD site is represented 
by a cross. The various cyto- 
tactin fusion constructs made 
in pGEX vectors are shown be- 
low the primary structure and 
labeled as presented in the text 
(see Materials and Methods). 
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cytotactin fragments. 10-12  % SDS-PAGE  gels under reducing con- 
ditions were stained using Coomassie blue. EGF, FN1, and FN3 are 
shown in their uncleaved (U) and cleaved (C) forms. FN2 and Fg 
are shown in their uncleaved form. The proteins (0.5-5.0 #g) were 
loaded in the order indicated in the figure. (B) Western blot analysis 
of the cleaved and uncleaved cytotactin  fragments as described 
above. The fusion proteins and the cleaved proteins show strong im- 
munoreactivity using a polyclonal cytotactin antibody. The GST 
bacterial portion does not show cross reactivity with this antibody 
(compare lanes labeled FN1 and FN3 in A and B). The molecular 
weights ￿  10  -3 of standard proteins are shown at the left of each 
panel. 
started extending processes.  None of the cell types tested 
bound to FN3 (Fig. 3, FN3). NIH-3T3 and U251MG ceils 
and a few neuro2A cells bound to fragment Fg (Fig. 3, Fg); 
the cells were essentially round but began to  show  small 
processes over the  time course of the  experiment.  Little 
binding was observed for any of the cell types on the FNFg2 
fragment (not shown).  This result suggested that the FN3 
fragment may antagonize the adhesive effects observed for 
the Fg fragment (see below). 
To demonstrate that cell attachment activities onto sur- 
faces coated with the different cytotactin fusion proteins did 
not result from artifacts due to the bacterial portion (GST) 
of the fusion protein, it was removed from the fragments by 
proteolytic cleavage as described in Materials and Methods. 
The cleaved fragments that were then tested presented adhe- 
sive properties identical to the uncleaved proteins.  When 
cleaved FN1 was tested for cell attachment and spreading, 
it showed the same activity as the intact fusion protein (Com- 
pare Fig. 3, FN1 with Fig. 4 B). For the cleaved EGF frag- 
ment, low levels of  adhesion with cell rounding was observed 
whereas no adhesion was observed for cleaved FN3 (Fig. 4, 
A and C). The GST fragment showed no adhesive activity 
in either the gravity (Fig. 4 D) or centrifugation assays (not 
shown) and served as a control for the experiments in which 
the uncleared proteins were used. 
Because earlier studies had shown that proteins that did 
not support high levels of cell attachment in the gravity assay 
could nevertheless show activity in other assays, we exam- 
ined the activity of  each fragment in the centrifugation assay. 
This assay allows the observation of interactions that are un- 
detectable in a gravity assay where weaker interactions of 
cells with the substratum allow the cells to be washed off 
(24). Using this assay, cell binding was observed for all frag- 
ments with the exception of FN3 (Table I). As shown in the 
table, the binding of a variety of cell types was scored using 
both assays and found to be qualitatively similar within a 
given cell type. 
Dependence of  Cell Attachment on Concentration of 
Cytotactin Fragments 
To determine whether the attachment of the three cell types 
to the different fusion proteins is concentration dependent 
and  saturable,  the  binding  of  NIH-3T3,  U251MG,  and 
neuro2As  was  determined  using  the  centrifugation assay 
(Fig. 5). To normalize the response of ceils to the different 
fragments, the diameter of the cell-free region within the 
ring of cells in the centrifugation assay was plotted with re- 
spect to moles of  protein actually bound to the wells as deter- 
mined  by  binding  of labeled  molecules  as  described  in 
Materials and Methods. 
Cell attachment was proportional to fragment concentra- 
tion and was saturable for each ceil type and each cytotactin 
fragment tested (Fig. 5). Differences were observed both in 
the amount of fragment at which the maximal measurable 
ceil  binding  was  obtained  and  in  the  maximal  binding 
achieved as measured by the diameter of  the ring of cells that 
adhere  along  the  sides  of the  well.  (These  two critical 
parameters were calculated from the graphs in Fig. 5 and are 
shown separately in Table ID. These are both useful parame- 
ters to assess the efficacy of cell attachment to the different 
proteins. It should be stated, however, that the mechanisms 
resulting in differences in cell binding cannot be determined 
from this type of assay alone. Differential ceil binding may 
be the result of differences in receptor affinity or number, or 
to secondary effects such as those involving the cytoskeleton 
or second messenger systems. 
Cell attachment to FN1 and FN2 was quantitatively simi- 
lar among the ceil types (Fig. 5, A-C), but for each ceil type, 
differences  were  observed  between  FN1  and  FN2.  The 
amount of fragment at which cell binding became saturated 
and  the  maximal  ring  diameter  at  saturating  fragment 
Prieto et al. Multiple  Binding  Domains of  Cytotactin/Tenascin  667 The Journal  of Cell Biology, Volume  119, 1992  668 Figure 4. Cell attachment to fusion proteins after removal of GST by proteolysis. NIH- 3T3 fibroblasts were allowed to bind in the gravity 
assay to plastic substrates  coated with cytotactin fragments after removal of the GST bacterial portion with activated factor Xa (FNI) or 
thrombin (EGF and FN3). The coating concentrations of the proteins are:  EGF,  12 #M (A); FN1,  2.8 #M (B); FN3,  11  /.tM (C); and 
to GST,  11.5 tiM (D).  Bar,  50 ~tm. 
amounts are shown in Table II. Maximal cell attachment  of 
U251MG  cells  and  neuro2A  cells  was  achieved  at  lower 
amounts of FN2 than FN1.  However, for each cell type,  the 
ring diameter was larger for FN1 than for FN2. These results 
suggest that the receptors mediating the binding to FN1  and 
FN2  may  not be identical on all cell types. 
The adhesive properties of the EGF domain of cytotactin 
were evident when the centrifugation  assay  was  used  (Fig. 
5,  D-F)  in  contrast  to  the  poor  binding  observed  in  the 
gravity assay (Fig. 4  and Table I). The adhesion of NIH-3T3 
cells (Fig, 5 D), U251MG cells (Fig. 5 E), and neuro2A cells 
(Fig. 5 F) to the EGF domain was approximately half of that 
observed for the Fg domain.  It is notable,  however, that the 
attachment  of each of the cell types  saturates  at a  very low 
amount of the EGF  fragment.  This may reflect differential 
receptor number or affinity for this region of the molecule. 
The concentration curve for the adhesion of neuro2A cells 
(Fig. 5 F) to the Fg domain was strikingly different from that 
Table I.  Quantitation  of Binding of Cell Types in Gravity and Centrifugation  Assays" 
Gravity  Centrifugation 
EGF  FNI  FN2  FN3  Fg  EGF  FN1  FN2  FN3  Fg 
Fibroblasts 
NIH3T3  +/-  + + + +  + + +  -  + + +  1.4  3.4  2.8  0  3.4 
CEF  +/-  ++++  +++  -  +++  1.2  3.4  2.1  0  3.4 
L929  -  + + +  + +  -  + +  0.7  3.4  1.0  0  3.4 
Glia 
Primary glia  -  + + +  + + +  -  + + +  0.7  2.1  1.5  0  3.4 
U251MG  +/-  + + +  + +  -  + +  0.5  3.4  0.5  0  2.8 
G2624  -  + + +  + +  -  + + +  0.5  3.4  1.0  0  3.4 
Neurons 
Neuro2A  -  + +  +  -  +  0.3  2.4  1.4  0  1.7 
SK-N-SH  -  + + +  -  -  -  0.3  3.4  1.0  0  2.1 
IMR  -  +  -  -  + +  0.7  3.4  2.4  0.3  2.8 
Other 
S180-L-CAM  -  + +  -  -  -  1.0  2.1  1.0  0  1.4 
P3U myeloma  -  + +  -  -  -  0  1.7  0  0  0 
* The symbols represent relative cell attachment to fragment-coated substrates. In a representative experiment the cell number in an area of 0.13 mm  2 would be 
the following: + + + +, 690 cells; + + +, 540 cells: + +, 370 cells; +, 185 cells. In the gravity assay the FN1, FN2 and Fg fusion proteins mediated very good 
cell attachment, EGF poor cell attachment, and FN3 only mediated cell attachment after trypsinization of the cells. 
Figure 3.  Cell attachment to fibronectin, cytotactin, and cytotactin fusion proteins.  3T3 fibroblasts (373),  neuro2A neuroblastoma cells 
(NzA), and  U251MG glioma cells (U251MG)  were allowed to bind in the gravity assay to plastic substrata  coated with proteins as de- 
scribed in Materials and Methods.  The frst two columns are substrata coated with either fibronectin (FN) or intact cytotactin (CT); the 
remaining columns are substrata coated with the indicated fusion proteins labeled as in Fig. 1. The coating concentration for each fragment 
was  12/zM;  for fibronectin, 0.3/zM;  and for cytotactin, 0.6/~M.  Bar,  50/zm. 
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NIH 3T3 Cells  U251MG Cells  N2A Cells 
pmoles of  Ring  pmoles of  Ring  pmoles of  Ring 
Fragment  fragment  diameter  fragment  diameter  fragment  diameter 
FN1  1.3  3.6  2.2  3.3  1.3  2.3 
FN2  0.7  1.7  0.7  1.4  0.5  0.8 
Fg  2.2  2.6  2.3  3.2  7.6  2.3 
EGF  0,7  1.6  0.4  1.3  0.8  2.0 
The pmoles of fragment and the ring diameter at saturation of  binding in the centrifugation  assay are shown for ease of comparison  between fragments and between 
cell types. 
* Extracted from Fig. 5. 
obtained  for  fibroblasts  and  glial  cells.  The  amount  of 
fibrinogen fusion protein required for cell attachment was 
approximately six times higher for the neuro2A cells than for 
the fibroblasts and glial cells. 
Trypsinization Uncovers Cell Attachment 
Activity to FN3 
The observations that fragment FN3 showed no adhesive ac- 
tivity in the gravity or centrifugation assays contrasted with 
earlier results of Spring et al. (66) who had proposed that 
a cell binding site was localized within this region on the ba- 
sis of tests on trypsinized cells. To investigate whether the 
differences between their study and the present results were 
due to the cell type used, the type of fusion protein, or to 
the method by which the cells were prepared and assayed, 
the experiment was repeated with cytotactic fragments fol- 
lowing four protocols, including that of Spring et al. (66) and 
with the cell line L929 as used previously (66). Four differ- 
ent methods of cell dissociation were tested (Fig. 6): 0.25 % 
trypsin alone (Fig. 6, A-C), 5 mM EDnA alone (Fig. 6 D), 
5 mM EDTA followed by washing and subsequent treatment 
with 0.25% trypsin (Fig. 6 E), a  mixture of 5 mM EDTA 
Figure 6. Trypsin treatment reveals biding to FN3. L929 cells initially dissociated with 0.25 % trypsin (A-C) were  plated onto tissue culture 
plastic dishes and coated with solutions containing decreasing concentrations of  FN3; 12/zM (A); 4 gM (B); 1.3/~M (C). Ceils dissociated 
with 5 mM EDTA (D), 5 mM EDTA followed by 0.25% trypsin (E), or a mixture of 5 mM EDTA and 0.25% trypsin (F) were plated 
onto substrates coated with 1.3/~M FN3. Bar,  100 #m. 
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the cells were further treated as described in Materials and 
Methods, resuspended in binding medium containing cal- 
cium, and tested on the substrates coated with each of the 
fusion proteins and with fibronectin, 
When cells were prepared by different methods, dramatic 
differences were found in cell attachment to FN3 (Fig. 6) but 
not to other fragments (not shown). Ceils treated with tryp- 
sin alone attached well to the surface coated with FN3 (Fig. 
6, A-C) and remained round.  Cells attached to the FN1 
coated area in the same dishes were spread suggesting that 
the  round  morphology on  FN3  did  not  result  from the 
method of cell preparation. Cells prepared with EDTA alone 
did not attach to FN3-coated plastic (Fig. 6 D), similar to 
the results described above for other cell types. Cells treated 
with EDTA and then with trypsin (Fig. 6 E) exhibited low 
binding similar to that in cells treated with EDTA  alone. 
Ceils  prepared  by  treatment  with  trypsin  together  with 
EDTA (Fig. 6 F), however, bound almost as well as cells pre- 
pared by trypsin treatment alone. These results suggest that 
trypsin treatment reveals a  cell binding activity for FN3. 
Moreover, the molecules coated on both tissue culture plastic 
dishes and polystyrene dishes also gave similar results, sug- 
gesting that cell attachment  to FN3 is not specific for the par- 
ticular type of plastic substrate. 
When cell attachment was compared on surfaces coated 
with decreasing concentrations of the FN3 fragment (Fig. 6, 
A-C), the highest cell binding was found on the area coated 
with the lowest concentration of fragment (Fig. 6  C). The 
adjoining uncoated area of the dish was completely devoid 
of ceils.  This inverse proportionality between cell attach- 
ment and fragment concentration suggests that an activity 
which prevents attachment exists in this domain and is re- 
vealed at high fragment concentration (see below). 
Effect of Cytotactin Fragments Mixed with the 
Permissive Substrate l~bronectin 
The observation that a cytotactin domain can prevent cell at- 
tachment and flattening is consistent with previous reports 
(34, 66). To determine whether any of the different cytotac- 
tin fragments modify cell binding to a  positive substrate, 
mixtures containing a constant concentration of fibronectin 
(0.3 t~M) and either of two concentrations of the fragments 
(12 and 1.3 t~M), were tested using the gravity assay (Fig. 7). 
Among the cytotactin fragments shown in Fig.  1,  three 
were found to decrease cell attachment significantly when 
mixed with fibronectin, relative to the attachment observed 
on fibronectin alone (Fig. 7). The decrease in cell attachment 
was '~30% in mixtures of fibronectin with FN2 and ~50% 
when either EGF or FN3 were present in the mixture at high 
concentration. This effect was concentration dependent; at a 
fragment concentration of 1.3/zM the number of attached 
cells increased for each fragment; although for the EGF and 
FN3 fragments, the binding was still significantly  lower than 
the control. 
The inhibition by FN2 was unexpected, given that FN2 
promoted cell attachment and spreading in the gravity assay 
in the absence of fibronectin (Fig. 3). In this experiment, at 
high concentrations of FN2,  ceils were significantly more 
aggregated than in the presence of any of the other frag- 
ments. This made the accurate counting of the bound cells 
difficult, possibly accounting for the lower numbers of at- 
tached cells. 
Figure 7. Cell attachment to fibronectin and cytotactin fragment 
mixtures. NIH-3T3  cells were  plated onto polystyrene-coated  dishes 
with solutions containing mixtures of 12 ~M (~) or 1.3 t~M (t3) 
cytotactin-fusion  proteins and 0.3/~M fibronectin. Fibronectin was 
mixed with BSA to determine the maximal attachment for in- 
dividual plates. The cells attached in four different fields were 
counted and averaged. The error bars represent SEM. The asterisks 
above each bar indicate the level of significance  compared with the 
fibronectin  control as judged by the t test; no asterisk indicates not 
significant. * P < 0.05; ** P < 0.01; and ***, P < 0.001. 
Counteradhesive Properties of the EGF and FN3 
Domains of Cytotactin 
The previous experiments suggested a counteradhesive ac- 
tivity within both the EGF and FN3  fragments. As men- 
tioned above, the amount of protein adsorbed to the plastic 
substrate is proportional to the concentration of the coating 
solution. In mixture experiments, the presence of  one protein 
might alter in some way the binding of the other. To address 
this possibility, mixtures of fibronectin and FN3 or EGF 
were prepared and cell attachment was correlated with the 
concentrations of  proteins bound to the plastic (Fig. 8). Mix- 
tures of 30/~g/ml of fibronectin and varying concentrations 
(1-300/~g/ml) of EGF (Fig. 8 A) or FN3 (Fig. 8 B) were 
tested. Each fragment inhibited cell attachment when high 
concentrations were mixed with fibronectin. At the highest 
fragment concentrations, cell attachment to fibronectin in 
the presence of  the EGF fragment was 40% of  maximal (Fig. 
8 A, I,  left axis) and attachment in the presence of the FN3 
fragment was only 10% of maximal (Fig. 8 B, mR, left axis). 
When  a  constant amount of iodinated  fibronectin (30 
#g/ml) was mixed with increasing concentrations of  the EGF 
fragment, the amount of labeled fibronectin bound to the 
polystyrene remained constant over the concentration range 
from 1-300 t~g/ml of the EGF fragment (Fig. 8 A, zx, right 
axis).  Similarly, the same amount of iodinated EGF frag- 
ment bound to the polystyrene  when it was mixed with either 
10, 30, or 100 t~g/ml of unlabeled fibronectin (not shown). 
Thus at a constant amount of fibronectin (30 t~g/ml), increas- 
ing concentrations of EGF fragment do not decrease the 
amount of fibronectin bound to the plastic. Similar results 
were observed with mixtures of fibronectin with FN1, FN2, 
and Fg fragments. This indicates that the decrease in cell at- 
tachment is due directly to the presence of  the EGF fragment 
and not to changes in the amount of fibronectin available for 
cell attachment. 
A different result was found with the FN3 fragment, how- 
ever. At increasing concentrations of FN3, decreasing con- 
centrations of fibronectin bound to the plastic (Fig. 8 B, 4, 
right axis). Conversely, increasing the concentration  of  fibro- 
nectin resulted in decreased binding of FN3 to the plastic 
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Figure  8.  Concentration- 
dependent  inhibition  of cell 
attachment  to  fibronectin  by 
mixture  with  EGF and  FN3 
cytotactin  fusion  proteins. 
Mixtures of 30 #g/ml of fibro- 
nectin and concentrations rang- 
ing from 0.3 to 7 #M of either 
EGF (A, m, left axis) or FN3 
(B,  -, left axis)  were coated 
on polystyrene dishes and the 
percent  of the maximum cell 
attachment  of NIH-3T3 cells 
was measured  in the  gravity 
assay. On the right y axis the 
amount of iodinated fibronec- 
tin  (rig/ram  2)  (zx in A and B, 
right axis) bound to the plastic 
at each coating concentration 
of fusion protein is shown. Er- 
ror bars represent  SEM. 
(not shown). The presence of FN3 interferes with fibronectin 
binding to a plastic substratum. At the highest concentration 
of EGF fragment, the concentration of fibronectin was re- 
duced 20-fold. It cannot be concluded from the mixture ex- 
periments with FN3, therefore, that FN3 inhibits cell binding 
to fibronectin. It is nevertheless clear from the results using 
trypsinized cells described above and from competition ex- 
periments (see below) that this fragment has counteradhesive 
activity. 
Inhibition of CeU Attachment by Soluble 
Cytotactin Fragments 
To substantiate further that the counteradhesive fragments 
acted by binding to the cell surface, a number of competition 
experiments were done.  In contrast to  cells preincubated 
with the control protein, BSA, (Fig. 9 A), preincubation of 
NIH-3T3 cells with cytotactin fusion proteins EGF (Fig. 9 
B), FN3 (Fig. 9 C), or with cytotactin itself (not shown) all 
decreased cell attachment to fibronectin-coated surfaces. It 
appears therefore that the interaction of cytotactin fragments 
with the cell surface is sufficient to inhibit cell attachment 
and spreading on fibronectin. 
Competition  experiments  were  also  used  to  determine 
whether the preincubation of cells with FN1, FN2, or intact 
cytotactin could alter the ability of the cell to attach to sub- 
strates coated with FN1.  After preincubation, the cells were 
Prieto et al. Multiple Binding Domains of Cytotactin/Tenascin  673 Figure 9. Inhibition of cell attachment to substrates by cell preincubation with soluble molecules.  (A-C) Polystyrene dishes coated with 
a solution of 100 t~g/ml  of fibronectin were incubated with cells that had been preincubated with 2 mg/ml of BSA (.4); EGF (B); or FN3 
(C). The cells that had been preincubated with EGF and FN3 show a rounded morphology when compared with those preincubated with 
albumin (A). (D-F) Polystyrene dishes coated with  12 #M FNI were incubated with cells that had been preincubated  with 2 mg/ml of 
BSA (D), FN1 (E), or intact cytotactin  (F). Fewer cells were observed when the cells were preincubated  either with FN1 (E) or with 
cytotactin  (F). In addition,  a dramatic  change in morphology  was observed in ceils preincubated  with cytotactin  (F). Bar, 50/~m. 
washed twice to remove the excess proteins.  As shown in 
Fig. 9, ceils preincubated with albumin attached and spread 
on FN1 (Fig. 9 D) in a fashion similar to unincubated cells 
(compare with Fig. 3). Cell binding and spreading were both 
reduced when the cells were preincubated with 30 #M FN1 
(Fig.  9  E)  or with  10  nM  purified cytotactin (Fig.  9  F). 
Preincubation of the cells with cytotactin had a  most dra- 
rnatic effect on cell number and morphology; fewer ceils at- 
tached to the substrate and the cells that did attach remained 
round (Fig.  9,  compare panels D  and F). 
These results were quantitated using different concentra- 
tions of FN1 coated on the substrate (Fig.  10).  When cells 
were preincubated with  30  #M  FN1  or 20  /~M FN2,  cell 
binding was reduced to 10-40% of maximal at FN1 coating 
concentrations lower than 7 #M,  as compared with control 
cells preincubated with albumin. At higher coating concen- 
trations of FN1,  soluble FN2 was a  less effective inhibitor 
than FN1. The fact that soluble molecules inhibit cell attach- 
ment to the immobilized molecule suggests that the binding 
of NIH-3T3 cells to FN1 occurs through specific cell surface 
receptors. 
Discussion 
Using fusion proteins generated in bacterial expression vec- 
tors, we have identified and characterized at least four dis- 
The Journal of Cell Biology, Volume 119, 1992  674 120 
'tOO ￿9 
80- 
o 
60 
20 
0  i 
0.00  2,00  4.o0  600  800 
Coaling FN1 Concentration (~M) 
Figure 10. Inhibition of cell attachment to FN1 by cell preincuba- 
tion with soluble BSA, FN1, and FN2 fragments is concentration 
dependent. Polystyrene dishes were coated with concentrations of 
FN1 ranging from 1 to 9 #M. The ceils were preincubated with 
2 mg/ml of soluble BSA (zx), FN1 (t~), or FN2 (4). The maximum 
number of ceils that attached to the highest concentration of FN1 
is defined  as 100%. The relative cell number in the presence of  each 
soluble protein in plotted versus the concentration of the FN1 that 
was used to coat the plastic. Error bars represent SEM. 
tinct, nonoverlapping regions in cytotactin that affected the 
cell attachment and morphology of three cell types, fibro- 
blasts, glia, and neurons. Fragments FNI, FN2, and Fg (see 
Fig.  1)  promoted cell attachment when coated onto sub- 
strates. Different cellular morphologies were observed after 
binding on these fragments; FN1 and FN2 allowed cells to 
spread whereas cells plated on Fg remained round. The EGF 
and FN3 regions were also able to inhibit cell attachment 
and spreading on fibronectin, and thus represent counter- 
adhesive substrates. Different methods were required to es- 
tablish  these findings.  For  example,  binding to  the  EGF 
domain was revealed in centrifugation assays and cell attach- 
ment to FN3 was uncovered by trypsinization of  the cells and 
was also demonstrated in competition assays. Quantitative 
studies showed that cell attachment to cytotactin domains is 
concentration dependent and saturable. These data are sum- 
marized in Table III and they are consistent with the hypoth- 
esis that independent cell surface receptors interact with the 
different protein regions of the molecule. Given the identical 
biological activities of the cleaved and uncleaved proteins, as 
well as their similarity to protex)lytic  fragments from the 
same regions of the native molecule, it is likely that these 
properties represent functions of the intact protein. This is 
supported by preliminary results of  the analysis of the secon- 
dary structure of the fusion proteins by circular dichroism. 
The results obtained indicated that both cleaved and uncleaved 
FN3  and uncleaved FN1  have significant/~-pleated sheet 
structure that would be expected for fibronectin type III re- 
peats. This is in contrast with the results obtained for Fg and 
EGF that showed a lower percentage of  ~-structure, It should 
also be noted that fusion proteins made in bacterial expres- 
sion systems such as those used here and by Spring et al. (66) 
lack the normal carbohydrates present in the native molecule. 
Given that native chicken cytotactin contains 17 potential 
glycosylation sites as well as two sites for the potential addi- 
tion of chondroitin sulfate (33,  39),  it is possible that the 
presence of appropriately linked carbohydrate may also be 
important in cytotactin functions. 
The fragments FN1  and FN2 that contain the proximal 
fibronectin type III (II-VI) repeats mediated cell attachment 
and spreading of most cell types tested, as did fibronectin. 
At decreasing concentrations of these fragments, the propor- 
tion of round to spread cells increased; this phenomenon has 
also been observed for fibronectin (75).  Chicken cytotactin 
contains a  single arginine-glycine-aspartate (RGD) tripep- 
tide, located in the third fibronectin type III repeat, which 
is present in both FN1 and FN2. RGD tripeptides have well- 
characterized binding activity to the integrin family of cell 
surface receptors  (36).  The present results are consistent 
with previous reports of RGD-dependent binding of cells to 
cytotactin (5,  24)  and with recent reports  that cytotactin 
binds to two members of the integrin family, ct/31 (a novel 
alpha subunit) (Mendler, M., A. Priest, and M. A. Bourdon. 
1991. J.  CellBiol. 115:137a) and a433 (Joshi, P., I. Aukhil, 
and H. P. Erikson.  1991. J.  Cell Biol.  115:134a;  Mendler, 
M., A. Priest, and M. A. Bourdon. 1991. J.  CellBiol.  115: 
137a) and that the binding can be inhibited by peptides con- 
taining the RGD sequence. Preliminary results (A. L. Prieto 
and K. L. Crossin, unpublished results) using the peptide 
GRGDS and its control GRADS showed that the cell spread- 
ing onto FN1 was clearly reduced by preincubation of cells 
with the active peptide, but not with the control. It should 
be noted, however,  that the RGD sequence in cytotactin is 
not conserved among species. It is absent from the mouse 
(73) and newt (58)  sequences, but is present in the human 
(31) and chicken (38, 66) sequences. Additional experiments 
using smaller fusion proteins will be required to determine 
Table III. Summary of Cell Attachment Activities of  Fibroblasts for Each of the Cytotactin Fragments 
Inhibition of 
Fragment  Binding,  gravity  Morphology  Binding, centrifugation  attachment to FN 
m./,n 
EGF  +/-  R  1.4  yes 
FN1  + +  +  +  S  3.4  no 
FN2  +  +  +  S  2.8  no 
FN3  - ( + + )*  - (R)*  0  yes 
Fg  ++ +  R  3.4  no 
As summarized in this table, two cytotactin fragments,  FN1 and FN2, promoted cell spreading (S) on substrates coated with them. Two sustained a rounded (R) 
cell morphology, EGF and Fg. FN3 only promoted  attachment and cell rounding after trypsinization  of the cells.  Using the more sensitive centrifugation assay, 
cell attachment to the EGF but not to the FN3 fusion proteins was observed. Both EGF and FN3 were able to inhibit cell attachment to fibroncctin-coated substrates. 
The binding and centrifugation  assays were scored  as described  in Tables I and II. 
* Only after trypsinization. 
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for the cell attachment and/or spreading of these fragments. 
Given the recent observation of disruption of focal contacts 
by the alternatively spliced type III repeats in human tenascin 
(57), additional cell binding sites may be present in FN2. 
This is also suggested by several of our binding analyses 
showing differential responses to FN1 and FN2. Given that 
the FN1 sequence is completely contained within FN2, the 
differential responses to FN1  and FN2  suggest additional 
sites and possible cooperative effects. 
More than one activity was found in fragment FN3, which 
spans the VII and VIII fibronectin type III repeats. In cells 
dissociated with EDTA, no cell attachment  to this region was 
detected by either the gravity or centrifugation assays. Cell 
attachment was uncovered, however, after the cells were dis- 
sociated with trypsin. The same results were obtained using 
the cleaved FN3 molecule. This result is consistent with the 
possibility of integrin-mediated cell attachment, inasmuch 
as integrins have been shown to be highly trypsin resistant 
in the presence of diwdent cations (70). A large number of 
integrins bind proteins other than fibronectin (36, 60, 67), 
many of which, like FN3, lack an RGD sequence (I7, 25, 30) 
and regions in fibronectin other than the RGD sequence have 
been shown to be important in integrin-mediated cell attach- 
ment (2). A cell attachment activity is located in the proxi- 
mal (II-VI) fibronectin type III repeats and cell attachment 
to the distal (VII-VUI) fibronectin type III repeats was ob- 
served only in trypsinized cells. This multiplicity of vari- 
ables that affects cell binding activity may explain differences 
among several previous reports (5,  12, 24, 66; Joshi, P., I. 
Aukhil, and H.  P.  Erikson.  1991. J.  Cell BioL  115:134a; 
Mendler, M,, A. Priest, and M. A. Bourdon. 1991. Z  Celt 
Biol.  115:137a) as to whether cells bind to intact cytotactin 
and whether this binding is sensitive to inhibition by RGD- 
containing peptides. 
A counteradhesive activity was definitely present in FN3 
since attachment was only observed at the lowest concentra- 
tions of FN3. Moreover, preincubation of cells with soluble 
FN3 also inhibited cell attachment and spreading on fibro- 
nectin. Thus, two activities are present in this fragment, one 
that promotes cell attachment of trypsinized cells and one 
that is counteradhesive and that prevents cell attachment on 
fibronectin. 
The EGF and FN3 fragments have activities that counter- 
act the adhesive effects of a  permissive substrate such as 
fibronectin,  as  previously described  for intact cytotactin 
(66).  The effect of the FN3 region was difficult to quantitate 
since this molecule displaced fibronectin from a plastic sub- 
strate when the two molecules were mixed. The possibility 
that FN3 interacts with fibronectin to cause the displacement 
is under investigation. The EGF fragment allowed cell at- 
tachment in the centrifugation assay and weak attachment in 
the gravity assay;  identical results  were obtained for the 
cleaved and purified fragment. Competition experiments es- 
tablished that both EGF and FN3 inhibit cell attachment and 
spreading on fibronectin by binding to the cell surface. The 
inhibition of cell attachment by soluble fragments supports 
the hypothesis  that receptor-mediated changes on the cell sur- 
face, rather than direct interference with fibronectin on the 
substratum, as suggested previously (46), are responsible for 
these counteradhesive effects. We refer to this effect as court- 
teradhesive to stress that it is surface mediated, very likely 
through independent surface receptors, and not likely to be 
mediated directly by competition for adhesive receptors. 
Early studies demonstrate that fibroblasts bind both to in- 
tact cytotactin and to a chymotryptic fragment derived from 
the carboxy-terminal end of the protein (24).  A previous re- 
port using cytotactin fusion proteins generated in a bacterial 
system (66) has assigned binding activities to two regions of 
cytotactin. A  cell binding region was localized to repeats 
equivalent to the FN3 fragment and an "antiadhesive" region 
was localized to the EGF-like repeats.  These authors ob- 
served decreased attachment of L-cells on tissue culture 
plastic coated with a fusion protein containing the EGF-like 
region of cytotactin. Surprisingly, a second report (9) using 
proteolytic fragments failed to observe inhibition of binding 
to  fibronectin-coated substrates  by  an  80-kD  proteolytic 
fragment of authentic tenascin that contained the EGF re- 
gion, but also contained one or more fibronectin type III 
repeats. In the same study (9), a 60-kD fragment containing 
the  three  distal-most  type  III  repeats  and  the  terminal 
fibrinogen knob was reported to have an antiadhesive effect 
in contrast to the earlier report that localized a cell binding 
site to this region (66). We propose that this effect is the same 
one detected here in the distal FN-type III repeats. These 
authors have also reported that a mAb Tn68 inhibits the an- 
tispreading effect of  cytotactin and have localized the epitope 
of Tn68 by EM to the last two fibronectin type three repeats 
(12). It is also significant that these investigators found that 
intact cytotactin has greater inhibitory activity than the 60- 
kD proteolytic fragment, suggesting that additional inhibi- 
tory activity was removed by this treatment. This supports 
the idea  that another inhibitory activity  exists amino-terminal 
to this fragment, consistent with both the present observa- 
tions and those of a counteradhesive activity within the EGF 
domain (66). 
Several extracellular matrix proteins have now been shown 
to  exhibit  counteradhesive  effects,  including  cytotactin/ 
tenascin (12,  24),  thrombospondin (45,  57),  and SPARC 
(secreted protein acidic and rich in cysteine), also called os- 
teonectin and BM-40 (62) and recently laminin (7 and for 
reviews see 10, 61). These proteins have been shown to in- 
hibit cell attachment and spreading, promote rounded cell 
shapes, and, in the case of cytotactin and SPARC, decrease 
the number of focal contacts (57).  No common sequence, 
structure, or receptors have so far been found among these 
proteins to account for similarities in some of  their activities. 
These phenomena clearly represent  cases  of cell surface 
modulation (18).  The possibility that all such effects  are 
mediated by a common mechanism involving the cytoskele- 
ton or second messenger systems is an important question 
for future study of each of these extracellular proteins. 
The present results suggest a model in which four different 
activities that modulate cell shape and cell adhesion can be 
assigned to specific regions within the cytotactin molecule; 
a fifth site is uncovered by proteolysis of the cell surface (Ta- 
ble III). Proteases are known to be activated at sites of cell 
migration, wounding, and tumors (1, 63, 64), sites at which 
cytotactin expression is also prominent (20).  Evidence has 
been presented (54), for example, that cytotactin polypep- 
tides containing the alternatively spliced repeats are more 
sensitive to proteolysis than those lacking these repeats. The 
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receptors may actually have  physiological relevance there- 
fore deserves further  consideration. 
The present results  also prompt the search for receptors 
that mediate these effects on cell attachment and morphology 
and provide a basis for that search. Clearly, differential  ex- 
pression of domain-specific receptors for cytotactin  might 
alter the responses of cells to the presence of the molecule. 
The activity of the intact cytotactin molecule would repre- 
sent a summation of its adhesive and counteradhesive activi- 
ties, providing a rationale for its observed amphitropic (19) 
properties.  Further  analysis  of the  cell  interactions  that 
mediate these effects will lead to a better understanding  of 
how cell-substrate interactions and subsequent cell surface 
modulations  regulate  developmentally  important  cellular 
processes  such  as proliferation,  migration,  neurite  exten- 
sion, and differentiation. 
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